Pulmonary Disease

Pulmonary disease is the third leading cause of death in the United States and continues to be a burden on public health across the world.  While numerous treatments exist that help ameliorate the symptoms of these diseases, the need for cures to these diseases remain in high demand.  Biomodels offers proven preclinical models that test the efficacy of potential therapies targeting various pulmonary diseases including: chronic obstructive pulmonary disease (COPD), allergic asthma, acute lung injury (ALI), adult respiratory distress syndrome (ARDS), as well as pulmonary fibrosis.  Specifically, Biomodels has the capability to perform functional lung mechanics measurements including airway hyper-reactivity (flexiVentTM), bronchoalveolar lavage fluid (BALF) analysis, histopathology, immunohistochemistry as well as numerous other common laboratory tests.  

Subscribe to RSS - Pulmonary Disease